Ikarian Capital »

Vyne Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $97k 290k 0.34
2025-06-30 $479k 290k 1.65

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Vyne Therapeutics

Baker Bros. Advisors
Acorn Capital Advisors
Shay Capital
Acadian Asset Management
Ikarian Capital
Two Sigma Investments
Vanguard Group
Jane Street
Geode Capital Management
Boothbay Fund Management
Bridgeway Capital Management
Susquehanna International
Two Sigma Advisers
Corsair Capital Management
Rangeley Capital

View all funds holding Vyne Therapeutics